Enlight Biosciences - Top 20 VC deals of 2008

Enlight Biosciences, FierceBiotech's top venture capital deals of 2008Company: Enlight Biosciences
Based: Boston, MA
Amount: $39M

Investors: Pfizer, PureTech Ventures, Merck Capital Ventures

Scoop: Eli Lilly, Merck and Pfizer joined forces with PureTech Ventures to launch Enlight Biosciences, an unusual venture that will spin off new companies based on promising technology. Enlight has already launched Endra, a biotech company that's pursuing a new approach to medical imaging.

Enlight Biosciences - Top 20 VC deals of 2008
Read more on

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.